Thursday , November 14 2019
Home / BUSINESS / EQUITIES / Strides Pharma Science gets EIR from USFDA for Alathur facility

Strides Pharma Science gets EIR from USFDA for Alathur facility

Strides Pharma Science has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for its formulations facility in Alathur, India. The inspection conducted in August 2019 had concluded with Zero 483 observations.

The facility has recently completed a significant capacity expansion and will support the growth momentum for the US business.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.